- Home
- ACR vs CADL Comparison
ACR vs CADL Comparison
Compare ACR & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACR
- CADL
- Stock Information
- Founded
- ACR 2005
- CADL 1999
- Country
- ACR United States
- CADL United States
- Employees
- ACR N/A
- CADL N/A
- Industry
- ACR Real Estate Investment Trusts
- CADL Biotechnology: Pharmaceutical Preparations
- Sector
- ACR Real Estate
- CADL Health Care
- Exchange
- ACR Nasdaq
- CADL Nasdaq
- Market Cap
- ACR 136.9M
- CADL 159.1M
- IPO Year
- ACR N/A
- CADL 2021
- Fundamental
- Price
- ACR $17.01
- CADL $6.60
- Analyst Decision
- ACR Buy
- CADL Strong Buy
- Analyst Count
- ACR 2
- CADL 1
- Target Price
- ACR $17.50
- CADL $11.00
- AVG Volume (30 Days)
- ACR 13.3K
- CADL 8.6M
- Earning Date
- ACR 10-30-2024
- CADL 11-14-2024
- Dividend Yield
- ACR N/A
- CADL N/A
- EPS Growth
- ACR N/A
- CADL N/A
- EPS
- ACR 0.83
- CADL N/A
- Revenue
- ACR $77,437,000.00
- CADL N/A
- Revenue This Year
- ACR N/A
- CADL N/A
- Revenue Next Year
- ACR N/A
- CADL N/A
- P/E Ratio
- ACR $20.77
- CADL N/A
- Revenue Growth
- ACR 8.77
- CADL N/A
- 52 Week Low
- ACR $9.41
- CADL $1.02
- 52 Week High
- ACR $17.77
- CADL $14.60
- Technical
- Relative Strength Index (RSI)
- ACR 52.63
- CADL 55.49
- Support Level
- ACR $17.09
- CADL $4.42
- Resistance Level
- ACR $17.53
- CADL $7.28
- Average True Range (ATR)
- ACR 0.24
- CADL 1.35
- MACD
- ACR -0.10
- CADL 0.26
- Stochastic Oscillator
- ACR 0.64
- CADL 22.48
About ACR ACRES Commercial Realty Corp.
ACRES Commercial Realty Corp is a commercial real estate investment trust that focuses on originating, holding and managing commercial real estate (CRE) mortgage loans and equity investments in commercial real estate properties through direct ownership and joint ventures. The company invests in commercial real-estate-related assets, including whole loans, A notes, B notes, mezzanine loans, and mortgage-related securities, as well as commercial finance assets, which include other asset-backed securities, senior secured corporate loans, equipment leases and notes, trust preferred securities, debt tranches of collateralize debt obligations, and private equity investments mainly issued by financial institutions.
About CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.